Bell Potter has retained a "speculative buy" on Starpharma.
"Starpharma announced that the US Patent and Trademark Office (USPTO) has granted a key patent covering the use of VivaGel for prevention of recurrence of Bacterial Vaginosis (R-BV).
Loading...
Elise Shaw writes on Markets specialising in Equity Markets, Commodities, Mining. Based in our Sydney newsroom, Elise has over 25 years experience as a finance and markets journalist and editor. Connect with Elise on Twitter.
